Report prepared for Minister of State for Public Health, Wellbeing and National Drugs Strategy by the HSE National Social Inclusion (Ireland)
Bibliography: Interventions – Harm Reduction
New report highlights public health and social risks posed by synthetic cannabinoids in Europe
Synthetic cannabinoids come under the spotlight today in a new report released by the EU drugs agency (EMCDDA)
A Strategic Framework to Tackle the Harm from Substance Use (2021-31)
This strategy sets out our proposals for tackling the harms caused by substance use over the next ten years (DoH, Ireland)
Drug Law Reform Report
It explores how existing legislation and its use impacts on the current situation amid the changing landscape of Scotland’s unique drug deaths challenge (Scottish Drug Deaths Taskforce)
Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats’ (ADAPT) Study Wave 4
The Australians’ Drug Use: Adapting to Pandemic Threats (ADAPT) Study is exploring the short and long-term impact of the COVID-19 pandemic on the experiences of Australians who use illicit drugs (NDARC)
NIN on drug health harms briefing – May 2021
This briefing summarises the topics covered at the May 2021 meeting of the national intelligence network (NIN) on the health harms associated with drug use, with updated information where appropriate (Public Health England)
Focused Policy Assessment of Reducing Harm, Supporting Recovery
An analysis of expenditure and performance in the area of drug and alcohol misuse (Government of Ireland)
People who inject drugs: HIV and viral hepatitis monitoring
Data tables and commentary for the unlinked anonymous monitoring surveys of infections and risk among people who inject drugs (Public Health England)
Canadian Opioid Use Disorder Guideline
Opioid Agonist Therapy: A Synthesis of Canadian Guidelines for Treating Opioid Use Disorder is a national clinical guideline that harmonizes existing provincial and national guidelines, evidence-based practices and expert opinions into one document aimed at providing consistent and high-quality care to people with opioid use disorder (camh)
Report detailing the work and further progress of the Drug Deaths Taskforce
Summarising its work in terms of innovation projects, research projects, and interventions through ADP direct funding under the categories of Emergency Response, Reducing Risk and Reducing Vulnerability, the Report offers an appraisal of how and when these will impact ( Scottish Drug Deaths Taskforce)
The Harms of Incarceration
The evidence base and human rights framework for decarceration and harm reduction in prisons – Prisons Briefing (Harm Reduction International)
Trends in, and characteristics associated with, trouble accessing sterile needles and syringes among people who inject drugs in Sydney, New South Wales
This bulletin highlights the percentage of participants amongst a sample of people who regularly inject drugs in Sydney, NSW who reported having trouble accessing sterile needles in the past month, from 2011-2019 (NDARC)
Successful ‘click and deliver’ naloxone service delivers lifesaving kits in the post to reduce drug-related deaths
Scottish Families Affected by Alcohol and Drugs (Scottish Families) has issued 348 naloxone kits in its first year of running its online ‘click and deliver’ service. People order online and receive their lifesaving kit in the post a few days later
Public Health England: ‘Preventable bacterial infections remain a problem’
Bacterial infections may be less likely to make the headlines than fatal overdoses and blood-borne viruses, but they are a source of considerable suffering among people who inject drugs (SSA)
Failure To Fund
The continued crisis for harm reduction funding in low- and middle-income countries download (HRI)
Who’s more likely to be able to get naloxone (Narcan) at their pharmacy?
A look at the socioeconomic factors associated with naloxone availability (Recovery Research Institute)
Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons
The results from this study provide a first glimpse into new developments emerging both during and in response to the pandemic, and which could have important implications for the future (EMCDDA)
HHS Releases New Buprenorphine Practice Guidelines, Expanding Access to Treatment for Opioid Use Disorder
The Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder exempt eligible physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and certified nurse midwives from federal certification requirements related to training, counseling and other ancillary services that are part of the process for obtaining a waiver to treat up to 30 patients with buprenorphine (SAMHSA)
Death Penalty For Drug Offences: Global Overview 2020
This report, our tenth on the subject, continues our work of providing regular updates on legislative, policy and practical developments related to the use of capital punishment for drug offences, a practice which is a clear violation of international law (Harm Reduction International)
Independent report Crime and policing
Includes Drivers of stop and search activity (b): tackling drug-related crime (Commission on Race and Ethnic Disparities)
- 1
- 2
- 3
- …
- 20
- Next Page »
